tiprankstipranks
Advertisement
Advertisement

TSE:VIVI Stock Latest News

TempraMed Wins Key Brazilian Patent for VIVI Box Medication Storage Platform
Company AnnouncementsTempraMed Wins Key Brazilian Patent for VIVI Box Medication Storage Platform
8d ago
TempraMed Moves Into Panama With TEM Distribution Deal to Boost Central American Reach
PremiumCompany Announcements
TempraMed Moves Into Panama With TEM Distribution Deal to Boost Central American Reach
16d ago
TempraMed Wins Chinese Patent for VIVI Box, Advancing Global Expansion Strategy
PremiumCompany Announcements
TempraMed Wins Chinese Patent for VIVI Box, Advancing Global Expansion Strategy
22d ago
TempraMed Bolsters VIVI Cap Reimbursement Case With New Clinical and Economic Evidence
PremiumCompany Announcements
TempraMed Bolsters VIVI Cap Reimbursement Case With New Clinical and Economic Evidence
1M ago
TempraMed Gains U.S. Physician Momentum as VIVI Cap Wins Clinical Endorsement
PremiumCompany Announcements
TempraMed Gains U.S. Physician Momentum as VIVI Cap Wins Clinical Endorsement
2M ago
TempraMed Expands Israeli Footprint With Super-Pharm Rollout
PremiumCompany AnnouncementsTempraMed Expands Israeli Footprint With Super-Pharm Rollout
2M ago
TempraMed Secures National Product Rollout with Israel’s Super-Pharm
Premium
Company Announcements
TempraMed Secures National Product Rollout with Israel’s Super-Pharm
2M ago
TempraMed Rolls Out VIVI Medication Protection Products Across Maccabi Pharmacies in Israel
Premium
Company Announcements
TempraMed Rolls Out VIVI Medication Protection Products Across Maccabi Pharmacies in Israel
2M ago
TempraMed Taps Dr. Phil’s Envoy Media to Accelerate U.S. Market Push for Medication Safety Solutions
PremiumCompany Announcements
TempraMed Taps Dr. Phil’s Envoy Media to Accelerate U.S. Market Push for Medication Safety Solutions
2M ago
TempraMed Expands Biologics Reach With Launch of VIVI Med Temperature-Protection Device
PremiumCompany Announcements
TempraMed Expands Biologics Reach With Launch of VIVI Med Temperature-Protection Device
3M ago
TempraMed Wins Validation for ROI Model, Paving Way to U.S. Payor Reimbursement
PremiumCompany Announcements
TempraMed Wins Validation for ROI Model, Paving Way to U.S. Payor Reimbursement
3M ago
TempraMed Enters Israeli Pharmacy Network with First Commercial Order
PremiumCompany Announcements
TempraMed Enters Israeli Pharmacy Network with First Commercial Order
3M ago
TempraMed Accelerates Global Expansion and Digital Push Ahead of 2026
PremiumCompany AnnouncementsTempraMed Accelerates Global Expansion and Digital Push Ahead of 2026
3M ago
TempraMed Expands South Korean Partnership as Injectable Drug Demand Surges
Premium
Company Announcements
TempraMed Expands South Korean Partnership as Injectable Drug Demand Surges
3M ago
TempraMed Unveils VIVI Cap Smart to Pair Drug Temperature Protection With Digital Health Tools
Premium
Company Announcements
TempraMed Unveils VIVI Cap Smart to Pair Drug Temperature Protection With Digital Health Tools
4M ago
TempraMed Expands U.S. Manufacturing Capacity with New Florida Facility
PremiumCompany Announcements
TempraMed Expands U.S. Manufacturing Capacity with New Florida Facility
4M ago
TempraMed Strengthens Scientific Advisory Board with Renowned Diabetes Expert
PremiumCompany Announcements
TempraMed Strengthens Scientific Advisory Board with Renowned Diabetes Expert
4M ago
TempraMed Expands Global Reach with Maccabi Healthcare Partnership
PremiumCompany Announcements
TempraMed Expands Global Reach with Maccabi Healthcare Partnership
4M ago
TempraMed Expands into Benelux with Salomo Executive Partnership
PremiumCompany Announcements
TempraMed Expands into Benelux with Salomo Executive Partnership
4M ago
TempraMed Expands Global Reach with Exclusive Distribution Deal in Israel
PremiumCompany AnnouncementsTempraMed Expands Global Reach with Exclusive Distribution Deal in Israel
5M ago
TempraMed Expands European Presence with Frankfurt Stock Exchange Listing
Premium
Company Announcements
TempraMed Expands European Presence with Frankfurt Stock Exchange Listing
5M ago
TempraMed Partners with Beyond Type 1 for 2025 NYC Marathon
Premium
Company Announcements
TempraMed Partners with Beyond Type 1 for 2025 NYC Marathon
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >